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We investigated the interactive relationship between proviral DNA load and virus-specific IFN-γ-secreting T cell responses in HIV-1C
infection. The presence or absence of correlation, and inverse or direct type of correlation, if any, were dependent on targeted viral gene product.
Responses to Gag p24 or to Pol were associated with lower proviral DNA load. Associations between proviral DNA load and T cell responses did
not necessarily mirror relationships between plasma RNA load and T cell responses. An interaction analysis showed a synergy in that lower
proviral DNA and lower plasma RNA load were associated with high Gag p24-specific IFN-γ-secreting T cell response (interaction test
P = 0.0003). Our findings support the idea that HIV proteins have differential value for vaccine design, and suggest that, for HIV-1C, Gag p24
may be one of the most attractive regions to include in vaccine designs to control both plasma RNA load and cell-associated proviral DNA load.
© 2006 Elsevier Inc. All rights reserved.Keywords: Proviral load; HIV-1; Subtype C; T cell responses; HumanIntroduction
A notable aspect of the dynamics and spread of the AIDS
epidemic has been the non-uniform distribution of HIV-1
subtypes (Kuiken et al., 2002; McCutchan, 2000; Osmanov et
al., 2002; Peeters and Sharp, 2000). The highest HIV incidence
and prevalence rates have been documented in the areas where
HIV-1 subtype C (HIV-1C) predominates (Bredell et al., 1998;
Kumwenda et al., 2001; Novitsky et al., 2002b; Osmanov et al.,
2002; Papathanasopoulos et al., 2002; Rollins et al., 2002; van
Harmelen et al., 1998; van Harmelen et al., 1999; Williamson et
al., 1995). Despite significant recent advances in the field of
HIV-1C research (Abebe et al., 1999; Björnal et al., 1999;
Choudhury et al., 2000; Gao et al., 1998; Masemola et al.,
2004a, 2004b; Mashishi et al., 2001; Neilson et al., 1999;⁎ Corresponding author. Fax: +1 617 739 8348.
E-mail address: messex@hsph.harvard.edu (M.E. Essex).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.02.006Novitsky et al., 1999, 2001, 2002a, 2002b, 2003; Peeters et al.,
1999; Renjifo et al., 2001, 2004; Rodenburg et al., 2001;
Salminen et al., 1996; Tscherning et al., 1998; van Harmelen et
al., 2001), the associations between immunological and
virological parameters in HIV-1C infection are still to be
elucidated. Better understanding these associations may reveal
correlates of protective immunity.
While plasma viral load is considered to be a major
prognostic marker for disease progression in HIV-1 infection
(Mellors et al., 1995, 1996, 1997), cell-associated proviral DNA
load also has unique prognostic value (Montano et al., 2003;
Pellegrin et al., 2003; Russell et al., 2001; Yerly et al., 2004).
The archiving of circulating plasma viruses primarily in T cells
creates an HIV reservoir (Finzi et al., 1997; Lambotte et al.,
2004; Persaud et al., 2003), which is sufficient to guarantee the
lifetime persistence of HIV-1. Although proviral load may be
reduced by HAART (Ngo-Giang-Huong et al., 2001), it never
reaches undetectable levels (Lillo et al., 2002), and it
143V.A. Novitsky et al. / Virology 349 (2006) 142–155contributes significantly to a subsequent rebound of viremia.
Technically, a reliable quantification of cell-associated proviral
load in HIV-1 infection became possible only relatively recently
after the real-time PCR technique was introduced (Brussel and
Sonigo, 2003; Chun et al., 2003; Desire et al., 2001; Douek et
al., 2002; Gibellini et al., 2004; Lillo et al., 2004; Montano et
al., 2003; Yun et al., 2002; Zhao et al., 2002). Most of these
studies quantified the proviral load of patients infected with
HIV-1 subtype B.
The role of virus-specific T cell responses in immune control
of HIV-1 infection has received much attention (Altfeld and
Rosenberg, 2000; Brander and Walker, 1999; Cao et al., 2003a;
Goulder, 2000; Goulder et al., 1999; Hanke and McMichael,
2000; Kalams and Walker, 1998; Letvin, 1998; Letvin and
Walker, 2003; Musey et al., 1997; Pantaleo et al., 1994; Picker
and Maino, 2000). HIV-1-specific CD4+ and CD8+ T cell
responses can be detected in long-term non-progressors or in
individuals who have been exposed to HIV-1 but remain
uninfected (Hladik et al., 2003; Kaul et al., 2001a, 2001b;
Mazzoli et al., 1997; Rowland-Jones et al., 1998; Schmechel et
al., 2001). It is apparent that in most cases of HIV-1 infection the
immune system fails to provide long-term control or elimination
of the virus. This inadequate immune control of virus
replication by virus-specific T cell responses can be at least
partially explained by the compromised function of T cell
responses (Appay et al., 2002; Champagne et al., 2001; Harari
et al., 2004; Lichterfeld et al., 2004a; Migueles et al., 2002;
Onlamoon et al., 2004; Papagno et al., 2004; Pitcher et al.,
1999; Yang et al., 2005), and/or the generation of viral escape
mutants (Allen et al., 2004; Borrow et al., 1997; Cao et al.,
2003b; Champagne et al., 2001; Couillin et al., 1994; Goulder et
al., 1997, 2001b; Koenig et al., 1995; Phillips et al., 1991; Price
et al., 1997; Wilson et al., 1999; Wolinsky et al., 1996).
Potential correlations between T cell responses and viral load
have been analyzed primarily based on plasma RNA load,
leaving associations between virus-specific T cell responses and
proviral DNA load understudied. There is an obvious
controversy in the field regarding observed associations
between immune responses and control of HIV-1 infection.
There are reports of direct correlations (Betts et al., 2001;
Buseyne et al., 2002b; Masemola et al., 2004a), inverse
correlations (Betts et al., 1999; Buseyne et al., 2002a; Chouquet
et al., 2002; Edwards et al., 2002; Greenough et al., 1997; Ogg
et al., 1998; Pontesilli et al., 1998), or no correlations (Addo et
al., 2003; Dalod et al., 1999; Gea-Banacloche et al., 2000;
Migueles and Connors, 2001) between virus-specific T cell
responses and viral load in HIV-1 infection. A recent report by
Lichterfeld et al. (2004a) indicated that virus-specific CD8+ T
cells were associated with lower viremia in acute HIV-1 subtype
B infection, but not in chronic infection. This suggests that the
timing of the virus-specific T cell responses during HIV-1
infection may also be important. Thakar et al. (2002) reported
subtype-specific differences in association between viral load
and Gag-specific immune responses. We demonstrated recently
that the associations between plasma viral load and virus-
specific T cell responses in HIV-1C infection vary depending on
the viral protein they target (Novitsky et al., 2003).In this study, we addressed the role of proviral DNA load in
the interaction with plasma viral load and virus-specific IFN-γ-
secreting T cell responses in HIV-1C infection. The results of
the study show a differential value of virus-specific T cell
responses directed at different HIV proteins, and may suggest
that Gag p24 is a key element in the correlates of protective
immunity in HIV-1C infection.
Results
It is important to clarify whether virus-specific IFN-γ-
secreting T cell responses can control the virus in the course of
HIV-1 infection. Assuming that functionally important T cell
responses help establish a low viral set point, we performed
analysis of relationships between proviral DNA load, plasma
RNA load, and HIV-1-specific IFN-γ-secreting T cell responses
(outlined in Fig. 1) in three complementary ways. First, we
addressed whether levels of proviral DNA and plasma RNA
load are related to the presence or absence of T cell responses
irrespective of magnitude or breadth of responses. For this
purpose, we compared mean levels of proviral DNA load and
plasma RNA load between subsets of responders and non-
responders. Second, we asked whether associations exist
between proviral DNA or plasma RNA load and cumulative
magnitude of T cell responses in HIV-1C infection. We
performed a linear regression analysis between proviral DNA
load and virus-specific IFN-γ-secreting T cell responses, and
between plasma RNA load and T cell responses within the
subset of responders only, and for the entire group. Finally, we
hypothesized that some interaction might exist between
virological and immunological parameters in HIV-1C infection.
The virus-specific T cell responses that can maintain low levels
of both proviral DNA load and plasma RNA load might be of
particular interest for HIV vaccine design.
Responders have lower proviral DNA and plasma RNA load
than non-responders
We analyzed patterns of total virus-specific T cell responses
(cumulative magnitude of T cell response directed at any viral
protein). We found that those who developed at least some
virus-specific IFN-γ-secreting T cell response had lower
proviral DNA load (mean value = 3.71 log10) than non-
responders (mean value = 4.47 log10; Wilcoxon test for
difference P = 0.011; Fig. 2). Likewise, responders had a
significantly lower plasma RNA load (mean value = 4.42 log10)
than non-responders (mean value = 5.27 log10; Wilcoxon test
for difference P = 0.0013; Fig. 2). In the sense of reducing viral
set point, these data might suggest a potentially protective role
of virus-specific IFN-γ-secreting T cell responses in HIV-1C
infection through the control, albeit partial, of the virus.
Differential role of HIV-1C-specific IFN-γ-secreting T cell
responses directed at different viral gene products
Relationships between proviral DNA or plasma RNA load
and T cell responses were dependent on the targeted viral gene
Fig. 1. Analyzed associations between proviral load, plasma viral load, and virus-specific IFN-γ-secreting T cell responses directed at the following HIV-1C proteins,
subregions, and immunodominant regions (defined in reference, Novitsky et al., 2002a). A cumulative magnitude of virus-specific IFN-γ-secreting T cell responses to
targeted viral proteins and their subregionswas analyzed. (A) Distribution of targeted viral gene products: Gag total, Gag p17, Gag p24, Gag p24161–190, Gag p24291–320,
Gag p24331–350, Gag p24161–190/291–320/331–350, Pol total, Pol Protease, Pol RT, Pol RT271–290/421–440, Pol RT271–290/421–440/521–540, Pol Integrase (IN), Pol
IN894–911/925–942, Vif, Vif61–90, Vpr, Vpr31–50, Tat, Tat36–50, Vpu, Env total, Env gp120, Env gp120299–319/552–571, Env gp41, Env gp41702–721/742–761, Nef total,
Nef82–96/122–141, Nef67–81/97–126, Nef67–141, and HIV-1C total. (B) Absolute number and percentage of responders analyzed per viral gene product, subregions and
immunodominant regions, and ration between the number of responders to the number of non-responders are shown.
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IFN-γ-secreting T cell responses directed at most individual
viral proteins or their subregions did not differ between
responders and non-responders. However, those who developed
virus-specific T cell responses directed at Gag and/or Pol had
significantly lower DNA and RNA load than those without
Gag- and/or Pol-specific T cell responses (Table 1). Particularly,
our data suggest an important role for virus-specific IFN-γ-
secreting T cell responses directed at Gag p24 and total
responses to Pol. Those who demonstrated detectable T cell
responses to Gag p24 and/or Pol had significantly lower
proviral load (mean difference = 0.97 log10 and 0.83 log10; P
values = 0.004 and 0.0001 for Gag p24 and Pol total,
respectively) and lower viremia (mean difference = 0.80 log10
and 0.59 log10; P values = 0.02 for both Gag p24 and Pol total)
as compared to non-responders. Notably, the important value of
Pol-specific T cell responses was not evident when the analysis
was based on the magnitude of response within only the
responders (Novitsky et al., 2003). As shown in Table 1, virus-
specific IFN-γ-secreting T cell responses directed at IDR within
Gag p24 were also linked to reduced proviral load (3 Gag p24IDRs161–190/291–320/331–350, Wilcoxon test P = 0.007), or
viremia (Gag p24 IDR161–190; Wilcoxon test P = 0.004).
Surprisingly, those who developed Tat-specific IFN-γ-secreting
T cell responses had higher proviral load as compared with
those who did not (Table 1; mean difference = −0.55 log10;
Wilcoxon test P = 0.009). A similar pattern was seen for Nef-
specific T cell responses, although the P value did not reach the
level of significance (t test P = 0.11; Wilcoxon test P = 0.13;
data not shown).
Differential correlation of virus-specific IFN-γ-secreting T cell
responses with proviral load vs. plasma viral load
We addressed whether the cumulative magnitude of virus-
specific IFN-γ-secreting T cell responses within the responder
group alone correlate with either proviral DNA load or plasma
RNA load. First, we analyzed relationships between proviral
DNA or plasma RNA load and magnitude of total virus-specific
IFN-γ-secreting T cell responses. Although no association was
found between plasma RNA load and magnitude of total T cell
responses (linear regression P value = 0.28), proviral DNA load
Fig. 2. Viral load within subsets of responders and non-responders (total virus-specific IFN-γ-secreting T cell responses). The boundary of the box closest to zero
indicates the 25th percentile, a dashed line within the box marks the mean value, a solid line within the box shows the median, and the boundary of the box farthest
from zero indicates the 75th percentile. Whiskers above and below the box indicate the 10th and 90th percentiles. Points above and below the whiskers indicate the 5th
and 95th percentiles.
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(linear regression P value = 0.046; the estimated slope was
−0.106 log10 for each 1000 SFC/106 PBMC), although the
correlation was weak (data not shown).
Next, we analyzed relationships between proviral DNA or
plasma RNA load and magnitude of virus-specific IFN-γ-
secreting T cell responses directed at different HIV-1C proteins,
cleavage products of viral proteins, and IDR. For proviral DNA
load, a unique pattern of significant associations with virus-
specific IFN-γ-secreting T cell responses was found that
differed from the associations for plasma viral load (Tables 2
and 3). T cell responses directed at Pol total correlated with
proviral load for the entire group (slope = −0.54 log10 per 1000
SFC/106 PBMC, P = 0.002) but not for the subset of responders
only. The association between proviral load and Pol RT-specificTable 1
Significant associations of virus-specific IFN-γ-secreting T cell responses with lowe
Proviral DNA load
Mean difference a, log10 t test,
P
value
Value 95% CI
Gag total 0.97 0.10; 1.83 0.03
Gag p24 0.97 0.32; 1.62 0.004
Gag p24161–190
Gag p24161–190/291–320/331–350 0.52 0.05; 0.98 0.03
Pol total 0.83 0.44; 1.23 0.0001
Pol integrase 0.41 0.06; 0.75 0.02
Tat total −0.55 −0.96; −0.14 0.01
Bolded P value indicates significant results after FDR adjustment at level 0.05.
a Mean difference delineates difference between mean values in responders and nIFN-γ-secreting T cell responses was evident for both
responders and the entire group. As shown in Table 2, responses
directed at Pol RT had slope = −0.51 and −0.40 log10 per 1000
SFC/106 PBMC for responders and the entire group, respec-
tively. T cell responses directed at the IDR within Pol RT also
demonstrated strong inverse correlations with proviral DNA
load (2 Pol IDR271–290/421–440 slope = −1.49 and −0.93 log10
per 1000 SFC/106 PBMC; P = 0.01 and 0.01 for responders and
for the entire group, respectively; and 3 Pol IDR271–290/421–440/
521–540 slope = −1.17 and −0.98 log10 per 1000 SFC/106
PBMC; P = 0.02 and 0.006 for responders and for the entire
group, respectively). We found a strong inverse correlation
between proviral DNA load and T cell responses directed at Vpr
IDR31–50 for the entire group (slope = −2.57 log10 per 1000
SFC/106 PBMC, P = 0.005). Virus-specific IFN-γ-secreting Tr proviral DNA and plasma RNA load in responders than in non-responders
Plasma RNA load
Wilcoxon
test,
P value
Mean difference a, log10 t test,
P
value
Wilcoxon
test,
P value
Value 95% CI
0.03 0.80 −0.07; 1.67 0.07 0.04
0.006 0.80 0.14; 1.46 0.02 0.009
0.46 0.04; 0.88 0.04 0.004
0.007
<0.001 0.59 0.10; 1.09 0.02 0.02
0.09
0.009
on-responders.
Table 2
Significant inverse correlation between virus-specific IFN-γ-secreting T cell responses and viral load: slopes and significance
Slope represents log10 decrease of viral load per 1000 SFC/10
6 PBMC.
Bolded P values indicate significant results after FDR adjustment at level 0.05.
a Subscript delineates amino acid positions of the immunodominant regions in HIV-1C proteins.
Table 3
Significant direct correlation between virus-specific IFN-γ-secreting T cell responses and viral load: slopes and significance
Slope represents log10 increase of viral load per 1000 SFC/10
6 PBMC.
Bolded P values indicate significant results after FDR adjustment at level 0.05.
a Subscript delineates amino acid positions of the immunodominant regions in HIV-1C proteins.
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147V.A. Novitsky et al. / Virology 349 (2006) 142–155cell responses at Pol Integrase IDR894–911/925–942 (slope = 1.55
log10 per 1000 SFC/10
6 PBMC, P = 0.04; responders only) or
Tat (slope = 0.69 log10 per 1000 SFC/10
6 PBMC; P = 0.05; the
entire group only) demonstrated direct correlation with proviral
load (Table 3), a phenomenon that warrants further studies. The
IFN-γ-secreting T cell responses directed at Nef correlated
directly with proviral DNA load for the entire group
(slope = 0.42 log10 per 1000 SFC/10
6 PBMC, P = 0.04).
Most of the associations between proviral DNA load and virus-
specific IFN-γ-secreting T cell responses directed at the
individual HIV-1C proteins or their subregions were not
statistically significant. Table 2 notes the 4 results with slope
significantly different from zero after FDR multiple compar-
isons adjustment.
Analysis of relationships between proviral DNA load and T
cell responses within MHC class I HLA supertypes A2, A24,
B27, B44, and B58 revealed very few significant associations:
RT-specific responses in A24 (slope = −0.42; 95% CI −0.68 to
0.08; P = 0.0195); Nef-specific responses in B44 (slope = 0.56;
95% CI 0.07 to 0.83; P = 0.029); Tat-specific responses in B58
(slope = 0.72; 95% CI 0.26 to 0.92; P = 0.0078); and Nef-
specific responses in B58 (slope = 0.58; 95% CI 0.02 to 0.87;
P = 0.0457).
For plasma RNA load, the strongest inverse associations
(Table 2) were observed with virus-specific IFN-γ-secreting T
cell responses directed at Gag (slope = −0.27 and −0.32 log10
per 1000 SFC/106 PBMC; P = 0.04 and 0.01 for responders and
the entire group, respectively), and Gag p24 (slope = −0.42 and
−0.51 log10 per 1000 SFC/106 PBMC, P = 0.02 and 0.002 for
responders and the entire group, respectively). In addition,
virus-specific IFN-γ-secreting T cell responses directed at Gag
p24 IDR161–190 and 3 Gag p24 IDRs161–190/291–320/331–350
showed significant correlation with plasma RNA load in the
entire group only (slope = −1.10 and −0.61 log10 per 1000 SFC/
106 PBMC; P = 0.001 and 0.005, respectively). In contrast,
plasma RNA load directly correlated with IFN-γ-secreting T
cell responses at Nef (Table 3; slope = 0.50 and 0.42 log10 per
1000 SFC/106 PBMC for responders and the entire group,Fig. 3. Association between proviral load andrespectively; P = 0.04 for each analysis). T cell responses at Nef
IDR67–81/97–126 directly correlated with plasma RNA load in the
subset of responders only (P = 0.04), while within the entire
group the P value did not reach statistical significance. No
significant associations were found between plasma RNA load
and virus-specific IFN-γ-secreting T cell responses directed at
other analyzed regions/subregions of HIV-1C proteins.
A synergy of proviral DNA load and plasma RNA load in their
association with IFN-γ-secreting Gag p24-specific T cell
responses
We tested for interaction between two virological para-
meters, namely proviral DNA load and plasma RNA load in
their relationships with virus-specific IFN-γ-secreting T cell
responses for the entire studied population and for the subset of
responders. A significant interaction test would be of particular
interest if high T cell response were associated with both low
proviral DNA load and low RNA load. We found a significant
association between proviral DNA load and plasma RNA load
(Fig. 3; slope = 0.29 log10 per 1000 SFC/10
6 PBMC;
P = 0.0042). The P value obtained from the Spearman rank
method provides evidence that there is some positive correla-
tion, while the point estimate of 0.29 suggests that this positive
correlation is weak.
The observed direct correlation between proviral DNA load
and plasma RNA load suggests that some interaction might
exist between these virological parameters in their relationships
with T cell responses, although correlation is also possible with
no interaction. Table 4 shows the results of the interaction
analysis (only significant results are shown, 3 of which are
significant after FDR adjustment). A significant interaction
between proviral DNA and plasma RNA load in relation to
virus-specific IFN-γ-secreting T cell responses was identified
for Gag, Gag p24, and Gag p24 IDR, while no interaction was
detected for other HIV-1C proteins or their subregions. The
results suggest a synergy, in which lower proviral DNA load
and lower plasma RNA load were associated with especiallyplasma viral load in HIV-1C infection.
Table 4
Interaction between proviral DNA load and plasma RNA load
F statistic P value
Responders only Responders +
Non-responders
Gag total 0.0011 0.00013
Gag p24 0.0017 0.000044
Gag p24161–190
a 0.0038 0.0073
Gag p24291–320 0.07 0.016
Gag p24161–190/291–320/331–350 0.01 0.001
Bolded P values indicate significant results after FDR adjustment at level 0.05.
a Subscript delineates amino acid positions of the immunodominant regions
across HIV-1C proteins.
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responses (Fig. 4). This effect was seen in linear regression
models of Gag p24-specific IFN-γ-secreting Tcell response that
included significant interaction terms (Table 5). The total R2 of
the model that excludes non-responders is 0.2828, F statistic P
value = 0.0017; and the total R2 of the model that includes the
entire group is 0.3526, F statistic P value = 0.000044.
Therefore, the model that includes the entire group of
responders plus non-responders is more predictive, and the
evidence for synergy/interaction in this case is the strongest.
The synergy of low plasma RNA load and low proviral DNA
load was also observed for the IFN-γ-secreting Gag-specific T
cell responses in the subset of responders, and the entire group
(data not shown). However, this was not the case for Gag p17-
specific T cell responses (R2 = 0.2568, F statistic P = 0.14 for
responders; R2 = 0.0459, F statistic P value = 0.48), or other
studied HIV-1C proteins and/or their subregions including IDR
(data not shown). These results suggest that the identified
synergy between proviral DNA load and plasma RNA load in
their association with virus-specific IFN-γ-secreting T cellFig. 4. Interaction of HIV-1C Gag p24-specific IFN-γ-secreting Tcell responses with
the coefficient estimates in the linear model (shown in Table 5), the top line shows th
load for an individual with high proviral load (at the 90th percentile: 41,210 copies o
individual with medium proviral load (at the 50th percentile: 5821 copies of prov
individual with low proviral load (at the 10th percentile: 417 copies of proviral DNresponses in HIV-1C infection suggests that Gag p24 and/or its
IDR may be attractive targets for vaccine design in inducing T
cell responses able to maintain low levels of both proviral DNA
and plasma RNA load.
Discussion
Understanding virus–host interactions with HIV-1C takes on
great significance in the context of the evolving dominance of
subtype C in the global AIDS epidemic. Our results demonstrate
diverse patterns of associations between virus-specific T cell
responses directed at different viral proteins (or their sub-
regions) and levels of proviral DNA and/or plasma RNA load,
and suggest that Gag p24-specific T cell responses might be
particularly important in virus containment in HIV-1C infection.
Associations that were found between the virologic and
immunologic parameters highlighted the complexity of virus–
host relationships in HIV-1C infection. First, associations
between both proviral DNA and plasma RNA load and HIV-
1C-specific IFN-γ-secreting T cell response are not uniform
and depend on the targeted viral gene product or its subregion.
Second, those who develop at least some virus-specific IFN-
γ-secreting T cell responses maintain lower proviral DNA
and/or plasma RNA load, and can better control virus as
compared with those who do not have virus-specific T cell
responses. Third, the presence of HIV-1C Gag p24-specific
IFN-γ-secreting T cell responses was associated with a
synergistic reduction of proviral DNA load and plasma
RNA load.
Most associations between proviral DNA or plasma RNA
load and HIV-1C-specific IFN-γ-secreting T cell responses
were weak and/or did not reach the level of statistical
significance. This is consistent with other studies that reported
no correlation between plasma viral load and T cell responses inplasma viral load at the 10th, 50th, and 90th percentiles of proviral load. Based on
e predicted log10 Gag p24 T cell response as a function of the log10 plasma viral
f proviral DNA per 106 PBMC). The middle line shows this relationship for an
iral DNA per 106 PBMC), and the bottom line shows this relationship for an
A per 106 PBMC).
Table 5
Linear regression models of IFN-γ-secreting Gag p24-specific T cell response
Responders only Responders + non-responders
Value Standard error t value Pr(>|t|) Value Standard error t value Pr(>|t|)
Intercept −2.8275 1.5116 −1.8706 0.0679 −2.9743 1.4010 −2.1230 0.0385
Log10 proviral DNA load 1.4244 0.4320 3.2972 0.0019 1.4836 0.3905 3.7991 0.0004
Log10 plasma RNA load 0.7919 0.3509 2.2564 0.0290 0.8382 0.3144 2.6658 0.0102
Log10 proviral DNA load × log10 plasma RNA load −0.3093 0.0989 −3.1253 0.0031 −0.3289 0.0853 −3.8561 0.0003
149V.A. Novitsky et al. / Virology 349 (2006) 142–155HIV-1 subtype B infection (Addo et al., 2003; Dalod et al.,
1999; Gea-Banacloche et al., 2000; Migueles and Connors,
2001). However, several HIV-1C-specific IFN-γ-secreting T
cell responses were significantly correlated with viral load. This
is consistent with other studies that show either inverse (Betts et
al., 1999; Buseyne et al., 2002a; Chouquet et al., 2002; Edwards
et al., 2002; Greenough et al., 1997; Ogg et al., 1998; Pontesilli
et al., 1998) or direct (Betts et al., 2001; Buseyne et al., 2002b;
Masemola et al., 2004a) correlation between viral load and T
cell responses.
We found that only select T cell responses are associated with
virus control, which provides evidence of a differential viral gene
product-dependent association of virus-specific IFN-γ-secreting T
cell responses in HIV-1C infection. The virus-specific IFN-γ-
secreting T cell responses directed at HIV-1C Gag p24 and
immunodominant regions within Gag p24 demonstrated the
strongest inverse correlation with proviral DNA and plasma
RNA load. We suggest that the magnitude and significance of the
slope can be used for quantification and comparison of potential
correlates of virus control. The magnitude of the slope is expressed
as the estimated log10 decrease of viral load per 1000 SFC/10
6
PBMC (including its 95% CI), and the P value quantifies evidence
for the slope being different from 0. These parameters can be useful
in identifying virus-specific T cell responses that exhibit strong
inverse correlation with viral load, and can help to identify
correlates of immune protection.
In contrast, a direct correlation between T cell response
directed at a particular viral protein or its subregion and viral
load is obviously not related to virus containment, and as such,
this viral gene product is unlikely to be a valuable target for
induction of T cell responses. For example, Nef-specific T cell
responses were directly associated with both proviral load and
plasma load. Nef-specific IFN-γ-secreting T cell responses
might reflect increased levels of viral load without efficient
containment of the virus. The biological significance of T cell
responses that are associated with higher proviral and/or plasma
load is not clear and requires a detailed analysis focusing on the
functional characteristics of virus-specific T cell responses.
HIV-1C-Pol-specific T cell responses represent an interesting
trend in relationships between proviral DNA or plasma RNA
and virus-specific T cell responses. Plasma RNA load was not
associated with total Pol-specific IFN-γ-secreting T cell
responses, while proviral DNA load showed an inverse
correlation for the entire group. The IFN-γ-secreting T cell
responses directed at subregions of Pol and particularly IDR
within Pol RT demonstrated an inverse correlation with proviral
load within the subset of responders and for the entire group. Incontrast, a direct association between proviral load and IFN-γ-
secreting T cell responses directed at Pol Integrase IDR894–911/
925–942 was evident within the subset of responders. Addition-
ally, for the entire group, a strong inverse correlation between
proviral load and Vpr IDR31–50-specific IFN-γ-secreting T cell
responses was observed in contrast to a moderate direct
correlation with Tat-specific responses.
The observed discrepancies in correlation between target-
specific and total viral-specific Tcell responses might be a result of
discordant T responses directed at different viral gene products or
their subregions. The total T cell responses were expressed as a
cumulative total magnitude of T cell responses directed at
individual viral proteins, and therefore, can include any pattern of
correlation observed at the level of a single viral protein or its
subregion. The inherited differences in variability of viral proteins
and their diverse expression levels during the course of HIV-1
infection may also contribute to the observed discrepancies. This
phenomenon might represent a complex virus–host interaction
reflecting differential selection pressure across viral proteins. A
resulting wide range of viral mutations may either lead to virus
escape from T cell responses or induce cross-reactive responses.
Both host and viral factors contribute to the outcome of this
dynamic interplay including determinants of host genetics and viral
functional constrains that limit virus escape potentially by affecting
viral fitness.
The overall results can be interpreted as an interesting trend of
inverse association between viral load and Tcell responses directed
at structural HIV-1C proteins, and direct correlation between viral
load and accessory viral proteins. Although it is likely that high
diversity and plasticity of accessory viral proteins may result in
faster escape from immune recognition and less efficient viral
control, it would be critical to reveal the biological mechanisms that
underline the distinct associations between structural and accessory
HIV-1 proteins in future studies. A recent report from Merck
supports better protective immunity induced by Gag and Env than
Tat after the SHIV-89.6P challenge in rhesusmonkeys (Liang et al.,
2005).
Results of our studies suggest that only subsets of virus-specific
T cell responses are associated with reduced viral load. This is in
accord with HIV-1B-based studies in humans that have provided
evidence that different subsets of virus-specific Tcells have distinct
phenotypic and functional properties. However, whether such
properties also differ for subsets of T cell responses directed at
different viral gene products is still an open question. The T cell
subsets differ in their ability to exert effector functions and to
control virus (Boritz et al., 2004; Harari et al., 2004; Lichterfeld et
al., 2004b; Younes et al., 2003). It is apparent that polyfunctional T
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than monofunctional IFN-γ-based responses (Pantaleo and Koup,
2004). Only subsets of T cells that are not functionally impaired
might be responsible for containment of the virus. Results of our
studies suggest that virus-specific T cell responses directed at
different viral gene products might have different functional
characteristics. The observed associations between proviral DNA
and/or plasma RNA load and T cell responses are biologically
sensible implying that virus-specific T cell activity is likely to
suppress virus replication. However, it is also likely that the
magnitude and frequency of virus-specific T cell responses might
be dependent to some extent on viral antigenic drive and might be
impaired by high virus load.
Our results suggest an important role of proviral DNA load as a
critical virological marker in HIV-1C infection, in addition to the
widely used plasma RNA load. While the level of viral RNA in
plasma is an important indicator of the total immune response to
HIV-1 infection, proviral DNA loadmight be a better measurement
of the effectiveness of virus-specific T cell responses. Cell-
associated proviral DNA load is more biologically related to the
potency of T cell responses than the level of viral RNA in plasma
because Tcells target infected cells rather than free circulating virus
in plasma. Although a significant portion of the proviral reservoir
might be replication-incompetent, presumably cells that harbor
defective provirus could still express some T cell antigens, and
therefore induce potent T cell responses able to target other cells
infected with replication-competent virus. In this study, we found
better correlation with total virus-specific IFN-γ-secreting T cell
responses than plasma RNA load and total T cell responses. In
contrast to the recent HIV-1B-based reports (Shiramizu et al.,
2004), we observed a correlation between plasma viral load and
proviral load (P = 0.0042), although it was not strong. In contrast to
the reported associations between plasma RNA load and T cell
responses within HLA supertypes (Novitsky et al., 2003), fewer
correlations were found between proviral DNA load and T cell
responses in the analyzed A2, A24, B27, B44, and B58 supertypes.
Further studies are needed to address whether proviral DNA load
can be a better indicator of antigen load than plasma RNA load in
relation to virus-specific T cell responses.
In summary, an association between immune response and
proviral DNA and plasma RNA load might point to a potential
correlate of protective immunity. We utilized cell-associated
proviral DNA load as an independent virologic parameter, and
investigated its relationships and interactions with plasma RNA
load and virus-specific IFN-γ-secreting Tcell responses in HIV-1C
infection. Our findings provide evidence for different associations
of virus-specific T cell responses with different HIV-1C proteins,
and suggest that Gag p24 may be a crucial component of a vaccine
designed for inducing T cell responses.
Materials and methods
Study subjects
The current analysis was performed with a sample set that
was collected from asymptomatic donors at the National Blood
Transfusion Center in Gaborone, Botswana and describedpreviously (Novitsky et al., 2001, 2002a, 2003). Sample
collection, peripheral blood mononuclear cells (PBMC) and
DNA isolation, and relevant information on the cohort were
described previously (Novitsky et al., 2001, 2002a). The total
number of study subjects was 105. Plasma RNA load data were
available for 103 cases (median 4.58 log10, range 3.27 log10).
Proviral DNA load was available for 101 cases (median 3.72
log10, range 4.37 log10). As described previously (Novitsky et
al., 2002a; Novitsky et al., 2003; Novitsky et al., 2001), samples
were assigned for screening of HIV-1C-specific T cell responses
based on actual PBMC viability and availability before any
relevant information including viral load, CD4, CD8, viral
sequence or HLA typing data had become available.
HIV-1C-specific IFN-γ-secreting T cell responses
Enumeration of virus-specific IFN-γ-secreting T cell responses
was performed by ELISPOT assay using synthetic peptides as
described previously (Novitsky et al., 2001, 2002a). The
predominant CD8+ specificity of analyzed IFN-γ-secreting T cell
responses was demonstrated previously by others (Goulder et al.,
2000, 2001a) and us (Novitsky et al., 2001) in a series of CD8+ and
CD4+ depletion and enrichment experiments. Nevertheless, we
refer to the analyzed virus-specific IFN-γ-secreting responses as T
cell responses because theCD8+andCD4+ specificity of responses
was not systematically quantified, which is a limitation of the study.
We used the cumulative magnitude of virus-specific IFN-γ-
secreting T cell responses to characterize responses to viral gene
products and/or subregions of viral gene products. For example,
virus-specific IFN-γ-secreting T cell responses to Gag represented
a sum of responses to all overlapping synthetic peptides spanning
Gag, and were expressed as “Gag total”; responses to Pol
represented a sum of responses to all overlapping synthetic
peptides spanning the Pol, andwere expressed as “Pol total” IFN-γ-
secreting Tcell responses. Similarly, “total HIV-1C-specific IFN-γ-
secreting T cell responses” represented a sum of responses to all
synthetic peptides from the full complement of viral proteins.
Responses to immunodominant regions (IDR; defined in Novitsky
et al., 2002a) included a sum of responses to synthetic peptides
across these regions. As defined earlier (Novitsky et al., 2002a),
IDR represent regions in HIV-1C proteins associated with top-
ranked T cell immune responses. Fig. 1A shows viral proteins and
IDR acrossHIV-1C that were included in analysis in this study. Fig.
1B demonstrates the absolute number and percentage of
responders, and ratio of responders to non-responders per analyzed
region. As described previously (Novitsky et al., 2001, 2002a), a
responder was defined as an individual who demonstrated
magnitude of virus-specific IFN-γ-secreting T cell response more
than 100 SFC/106 PBMC to synthetic peptides spanning the
analyzed viral gene product or its subregion.
HIV-1C cell-associated proviral DNA load
Quantification of proviral load was performed by real-time PCR
using theRoche LightCycler. TheHIV-1C gag p24was targeted for
quantification of the proviral DNA load. Cell-associated proviral
copy number was normalized to albumin levels. Briefly, 5 μl of
151V.A. Novitsky et al. / Virology 349 (2006) 142–155isolatedDNA (∼ 500 ng)was added to the PCRmixture (total PCR
volume of 20 μl) containing 4 mMMgCl2, 0.8 μM of p24 primers
(pair p24-F1/L330) or 0.5 μM of albumin primers (pair ALB-S/
ALB-AS), 0.5 μM of p24-specific (KS220) hydrolysis probe or
0.3 μM of albumin-specific (ALB-FAMProbe) hydrolysis probe,
and 2 μl of LightCycler Fast Start DNA master mix hybridization
probe kit (Roche Applied Science, Indianapolis, IN). The sequence
of the forward primer p24-F1 was 5′-CAA GCA GCC ATG CAA
ATGTT-3′ (HXB2 positions 1372 to 1391), and the reverse primer
L330 was 5′-GGTACTAGTAGTTCCTGCTAT-3′; the forward
primerALB-Swas 5′-GCTGTCATCTCTCTTGTGGGCTGT-
3′ (HXB2 positions 1515 to 1495), and the reverse primerALB-AS
was 5′-AAACTCATGGGAGCTGCTGGTT-3′. The size of the
p24 amplicon was 142 bp. The probes were labeled at the 5′ end
with the reporter dye, 6-carboxy fluorescein (FAM), and at the 3′
end with the quencher dye, N,N,N′,N′-tetramethyl-6-carboxy-
rhodamine (TAMRA). The sequence of theKS220 probe (modified
SK102 probe for HIV-1C) was 5′-FAM-ATC AAT GAG GAG
GCT GCA GAATGG GA-TAMRA-3′ (HXB2 positions 1402 to
1427); the sequence of the ALB-FAMProbe was 5′-FAM-CCT
GTC ATG CCC ACA CAA ATC TCT CC-TAMRA-3′. The
LightCycler “touch-down” PCR protocol for the p24 quantification
was as follows: denaturation at 95 °C for 10 min (1 cycle); a 3-step
reaction consisting of 10 s at 95 °C, 10 s at 68 °C decreasing to
60 °C one degree per cycle for the first 8 cycles and remaining at
60 °C afterwards, and 10 s at 72 °C (55 cycles); and 40 °C for 30 s (1
cycle). The temperature-transition rate was 20 °C per second
throughout the protocol. The LightCycler “touch-down” PCR
protocol for the albumin quantificationwas as follows: denaturation
at 95 °C for 10 min (1 cycle); a 3-step reaction consisting of 10 s at
95 °C, 15 s at 60 °C decreasing to 55 °C one degree per cycle and
remaining at 55 °C, and 12 s at 72 °C (55 cycles); and 40 °C for 30 s
(1 cycle). The temperature-transition rate was 20 °C per second for
the denaturation step and 10 °C per second for the annealing and
extension steps. Fluorescence was monitored once during each
cycle at the end of the annealing phase. The LightCycler software
package (ver.3.5) was used for amplification, data acquisition, and
analysis. The channel setting was F1/F2 with the fit points mode
and proportional baseline adjustment for both p24 and albumin
quantification. For each p24 run, a standard curve was generated
from 8E5 cell line DNA ranging from 104 to 100 copies per
reaction. For each albumin run, a standard curve was generated
from the LightCycler Control kit DNA (15 ng/μl human genomic
DNA; Roche Applied Science). All samples were tested in
duplicate. If a difference between duplicate samples exceeded
10%, samples were re-run in triplicate. The average value was used
in analysis. The cell-associated proviral copy number was
expressed as log10 of proviral DNA copy number per 10
6
PBMC (based on the albumin copies in the same samples). The
threshold of detection was 10 copies/106 PBMC.
Statistical analysis
Statistical analysis and basic graphical presentations were
performed by Splus v.6.0 (Insightful Corp.), and Microsoft
Excel 2002 (Microsoft Corp.) enhanced by the package
Analyse-it (Analyse-it Software, Ltd.). Linear regression modelswere used to estimate the linear correlation (slope) between log10
plasma RNA load or log10 proviral DNA load and HIV-1C-
specific IFN-γ-secreting T cell responses within each viral gene
product or its IDR, and to test for a zero slope. These models
were also used to assess correlations adjusted for CD4 and CD8
counts, and to test for interactions between virologic and
immunologic parameters. For each viral gene product and its
subregion, an assessment of correlation was performed for all
subjects and for responders only. Patterns of association were
compared in two groups, responders and non-responders. The
interaction tests were done for all subjects and for responders
only.Wilcoxon tests were used to compare viral loads between T
cell responders and non-responders. All tests were two-tailed,
and P values <0.05 indicated statistical significance.
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